“The order situation for our medical technology products is excellent at the moment. We’ve been able to exceed the 2008 annual figures already in the first quarter of 2009”, stated Andreas Dornbierer, President of Lobeck Medical AG, before adding: “We have seen increased demand for our blood glucose meter, MediSmart® of Switzerland Sapphire, not only in Western Europe but also in Eastern Europe and South America, where the order situation looks very healthy.”
Lobeck Medical AG can also report increased sales figures in the area of in-vitro diagnostics. “We anticipate a clearly increased demand in the coming years, especially for our colon cancer early-detection tests, because awareness of the subject of colon cancer is constantly on the increase in public discourse”, comments Andreas Dornbierer, with the clarification:
The MediSmart® Colon Cancer Early Detection Test allows everyone to determine, in a private environment and with very little expenditure of time and money, whether there exists the need for further examinations, such as a colonoscopy, and thus clearly reduces the risk of falling ill with colon cancer.
Lobeck Medical AG’s product portfolio is now even more focused on individuals who wish to practice preventative healthcare without having to permanently consult a physician. Lobeck Medical AG will serve this market even more effectively in the future with its user-friendly and inexpensive products. It is the long-term goal of the company to establish itself in further global markets with innovative new products in the medical technology sphere.
# # #
About the company:
The Lobeck Medical AG develops and distributes user friendly product solutions for the medical diagnostics market with focus on diabetes (glucometer)